However, in the cancer context, the M2 tumor‐associated macrophages (TAMs) in TME typically augment tumor cell proliferation, promote angiogenesis, and suppress T cell‐mediated antitumor immune response by secreting transforming growth factor‐β and interleukin‐10 (IL‐10) as well as T cell immune checkpoint ligands.12, 13, 14. Here, IL10 is linked to neoplasm.